The results showed a time-dependent suppression of expression and phosphorylation in cancer cell lines, leading to the hypothesis that niclosamide has an inhibitory effect on the upstream regulators of the ERK cascade, while also preventing the adequate functioning of their downstream mediators. The gene discussed is MAPK1; the disease is cancer.